FOCUS: A Phase I/II First in Human Study to Evaluate the Safety and Efficacy of GT005 Administered in Subjects With Dry AMD
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Geographic Atrophy
Related studies linked through entity extraction aliases.
Phase 2/3 Study of ALK-001 in Geographic Atrophy
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
GOLDEN STUDY: A Study to Assess Safety and Efficacy of Multiple Doses of IONIS-FB-LRx in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (AMD)
- Status
- COMPLETED
- Phase
- PHASE2
Study to Evaluate the Safety of Intravitreal APL-2 in Patients Diagnosed With Geographic Atrophy
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration
- Status
- COMPLETED
- Phase
- PHASE3
Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Efficacy of IONIS-FB-Lrx in up to 120 Patients 55 and Older With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
- Status
- WITHDRAWN
- Phase
- PHASE2
Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy and Safety Study of CNTO 2476 in Participants With Visual Acuity Impairment Associated With Geographic Atrophy (GA) Secondary to Age Related Macular Degeneration (AMD)
- Status
- WITHDRAWN
- Phase
- PHASE2
Subthreshold Laser Treatment for Reticular Pseudodrusen and Geographic Atrophy Secondary to AMD
- Status
- COMPLETED
- Phase
- NA
Long-Term Safety of Lampalizumab Intravitreal (ITV) Injections in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (OMASPECT)
- Status
- TERMINATED
- Phase
- PHASE3
Zimura in Participants With Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Metformin for the Minimization of Geographic Atrophy Progression in Patients With AMD
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Evaluate the Safety and Clinical Response of Subretinal Administration of CNTO 2476 in Participants With Geographic Atrophy
- Status
- COMPLETED
- Phase
- PHASE2
Study of Subretinal Implantation of Human Embryonic Stem Cell-Derived RPE Cells in Advanced Dry AMD
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
CLG561 Proof-of-Concept Study as a Monotherapy and in Combination With LFG316 in Subjects With Geographic Atrophy (GA)
- Status
- COMPLETED
- Phase
- PHASE2
Study of Pegcetacoplan (APL-2) Therapy in Patients With Geographic Atrophy
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Disease Progression in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
- Status
- TERMINATED
- Phase
- N/A
A Study of Disease Progression in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
- Status
- TERMINATED
- Phase
- N/A
Geographic Atrophy and Intravitreal Ranibizumab Injections
- Status
- UNKNOWN
- Phase
- N/A